220 related articles for article (PubMed ID: 25239643)
1. The role of miR-200a in mammalian epithelial cell transformation.
Becker LE; Takwi AA; Lu Z; Li Y
Carcinogenesis; 2015 Jan; 36(1):2-12. PubMed ID: 25239643
[TBL] [Abstract][Full Text] [Related]
2. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
Chen WY; Xu YY; Zhang XY
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
[TBL] [Abstract][Full Text] [Related]
3. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells.
Eades G; Yao Y; Yang M; Zhang Y; Chumsri S; Zhou Q
J Biol Chem; 2011 Jul; 286(29):25992-6002. PubMed ID: 21596753
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice.
Liu Y; Miao Y; Gao X; Wang YY; Wang H; Zheng YW; Zhao ZY
Cell Physiol Biochem; 2018; 50(6):2365-2389. PubMed ID: 30423573
[TBL] [Abstract][Full Text] [Related]
5. Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.
Ngalame NN; Tokar EJ; Person RJ; Xu Y; Waalkes MP
Toxicol Sci; 2014 Apr; 138(2):268-77. PubMed ID: 24431212
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-200a induces EMT phenotypes and CSC-like signatures through targeting the β-catenin pathway in hepatic oval cells.
Liu J; Ruan B; You N; Huang Q; Liu W; Dang Z; Xu W; Zhou T; Ji R; Cao Y; Li X; Wang D; Tao K; Dou K
PLoS One; 2013; 8(11):e79409. PubMed ID: 24260215
[TBL] [Abstract][Full Text] [Related]
7. Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
Konishi H; Karakas B; Abukhdeir AM; Lauring J; Gustin JP; Garay JP; Konishi Y; Gallmeier E; Bachman KE; Park BH
Cancer Res; 2007 Sep; 67(18):8460-7. PubMed ID: 17875684
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A.
Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK
BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639
[TBL] [Abstract][Full Text] [Related]
9. MiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4.
Meza-Sosa KF; Pérez-García EI; Camacho-Concha N; López-Gutiérrez O; Pedraza-Alva G; Pérez-Martínez L
PLoS One; 2014; 9(9):e103987. PubMed ID: 25181544
[TBL] [Abstract][Full Text] [Related]
10. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
11. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
13. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
[TBL] [Abstract][Full Text] [Related]
14. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
[TBL] [Abstract][Full Text] [Related]
15. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways.
Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X
Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919
[TBL] [Abstract][Full Text] [Related]
16. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
[TBL] [Abstract][Full Text] [Related]
17. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
[TBL] [Abstract][Full Text] [Related]
18. Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells.
Qian P; Banerjee A; Wu ZS; Zhang X; Wang H; Pandey V; Zhang WJ; Lv XF; Tan S; Lobie PE; Zhu T
Cancer Res; 2012 Nov; 72(22):6036-50. PubMed ID: 23019226
[TBL] [Abstract][Full Text] [Related]
19. Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.
Wang GM; Wong HY; Konishi H; Blair BG; Abukhdeir AM; Gustin JP; Rosen DM; Denmeade SR; Rasheed Z; Matsui W; Garay JP; Mohseni M; Higgins MJ; Cidado J; Jelovac D; Croessmann S; Cochran RL; Karnan S; Konishi Y; Ota A; Hosokawa Y; Argani P; Lauring J; Park BH
Cancer Res; 2013 Jun; 73(11):3248-61. PubMed ID: 23580570
[TBL] [Abstract][Full Text] [Related]
20. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
Li Y; Ma X; Wang Y; Li G
Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
